Name
Title
Email
Robert Goldsmith
Senior Vice President, Sales, MJH Life Sciences & OncLive®
rgoldsmith@mjhassoc.com
Lisa Greene
Vice President, Sales, OncLive® Medical
lgreene@onclive.com
Albert Tierney
Senior Director, Sales, OncLive®
atierney@onclive.com
Morgan Michon
Director of Sales, OncLive®
mmichon@onclive.com
Shane Marchesani
National Accounts Manager, OncLive®
smarchesani@onclive.com
Elisha Garcia
Senior Accounts Manager, OncLive® Events
egarcia@onclive.com
Chelsea DeLisa
National Accounts Manager, OncLive® Events
cdelisa@onclive.com
Gabby Gelchion
National Accounts Associate, OncLive® Events
ggelchion@onclive.com
Alyssa Tomaseck
Business Development Associate, OncLive® Medical
atomaseck@onclive.com
Mike DiGrazia
Inside Sales Associate, OncLive®
mdigrazia@onclive.com
Noelle Stango
Strategic Alliance Partnership Coordinator, OncLive® & ONN
nstango@mjhlifesciences.com
MK-1084 Alone and Plus Pembrolizumab Shows Early Safety, Activity in KRAS G12C+ Solid Tumors
First-Line Anlotinib Plus Etoposide and Carboplatin Improves PFS in ES-SCLC
Concurrent Durvalumab/CRT Does Not Confer Significant Survival Advantage in Unresectable Stage III NSCLC
Phase 2 IMscin002 Study Shows Patients With NSCLC Prefer Subcutaneous Atezolizumab